Literature DB >> 26228885

Accuracy of Preoperative Imaging in Detecting Nodal Extracapsular Spread in Oral Cavity Squamous Cell Carcinoma.

A H Aiken1, S Poliashenko2, J J Beitler3, A Y Chen4, K L Baugnon5, A S Corey5, K R Magliocca6, P A Hudgins5.   

Abstract

BACKGROUND AND
PURPOSE: The increasing impact of diagnosing extracapsular spread by using imaging, especially in patients with oropharyngeal squamous cell carcinoma, highlights the need to rigorously evaluate the diagnostic accuracy of imaging. Previous analysis suggested 62.5%-80.9% sensitivity and 60%-72.7% specificity. Our goals were to evaluate the accuracy of imaging in diagnosing extracapsular spread in a cohort of patients with oral cavity squamous cell carcinoma (pathologic confirmation of extracapsular spread routinely available), as a proxy for oropharyngeal squamous cell carcinoma, and to independently assess the reliability of imaging features (radiographic lymph node necrosis, irregular borders/stranding, gross invasion, and/or node size) in predicting pathologically proven extracapsular spread.
MATERIALS AND METHODS: One hundred eleven consecutive patients with untreated oral cavity squamous cell carcinoma and available preoperative imaging and subsequent lymph node dissection were studied. Two neuroradiologists blinded to pathologically proven extracapsular spread status and previous radiology reports independently reviewed all images to evaluate the largest suspicious lymph node along the expected drainage pathway. Radiologic results were correlated with pathologic results from the neck dissections.
RESULTS: Of 111 patients, 29 had radiographically determined extracapsular spread. Pathologic examination revealed that 28 of 111 (25%) had pathologically proven extracapsular spread. Imaging sensitivity and specificity for extracapsular spread were 68% and 88%, respectively. Radiographs were positive for lymph node necrosis in 84% of the patients in the pathology-proven extracapsular spread group and negative in only 7% of those in the pathologically proven extracapsular spread-negative group. On logistic regression analysis, necrosis (P = .001), irregular borders (P = .055), and gross invasion (P = .068) were independently correlated with pathologically proven extracapsular spread.
CONCLUSIONS: Although the specificity of cross-sectional imaging for extracapsular spread was high, the sensitivity was low. Combined logistic regression analysis found that the presence of necrosis was the best radiologic predictor of pathologically proven extracapsular spread, and irregular borders and gross invasion were nearly independently significant.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26228885      PMCID: PMC7968765          DOI: 10.3174/ajnr.A4372

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  [The extracapsular spread of cervical lymph node metastases: the diagnostic value of computed tomography].

Authors:  H J Steinkamp; E van der Hoeck; J C Böck; R Felix
Journal:  Rofo       Date:  1999-05

2.  Pitfalls in the staging of cervical lymph node metastasis.

Authors:  Amit M Saindane
Journal:  Neuroimaging Clin N Am       Date:  2013-02       Impact factor: 2.264

3.  Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: pilot study.

Authors:  R A Zoumalan; A J Kleinberger; L G T Morris; A Ranade; H Yee; M D DeLacure; D Myssiorek
Journal:  J Laryngol Otol       Date:  2010-06-24       Impact factor: 1.469

4.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

Authors:  Brian O'Sullivan; Shao Hui Huang; Lillian L Siu; John Waldron; Helen Zhao; Bayardo Perez-Ordonez; Ilan Weinreb; John Kim; Jolie Ringash; Andrew Bayley; Laura A Dawson; Andrew Hope; John Cho; Jonathan Irish; Ralph Gilbert; Patrick Gullane; Angela Hui; Fei-Fei Liu; Eric Chen; Wei Xu
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

5.  Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status.

Authors:  Jessica H Maxwell; Robert L Ferris; William Gooding; Diana Cunningham; Vikas Mehta; Seungwon Kim; Eugene N Myers; Jonas Johnson; Simion Chiosea
Journal:  Cancer       Date:  2013-06-24       Impact factor: 6.860

6.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

7.  Accuracy of CT in detecting squamous carcinoma metastases in cervical lymph nodes.

Authors:  P Carvalho; D Baldwin; R Carter; C Parsons
Journal:  Clin Radiol       Date:  1991-08       Impact factor: 2.350

8.  Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma.

Authors:  Y H Joo; I R Yoo; K J Cho; J O Park; I C Nam; M S Kim
Journal:  Int J Oral Maxillofac Surg       Date:  2012-12-06       Impact factor: 2.789

9.  Sensitivity and specificity of computed tomography for detection of extranodal spread from metastatic head and neck squamous cell carcinoma.

Authors:  M A Souter; R S Allison; J H Clarkson; I A Cowan; M H Coates; J E Wells
Journal:  J Laryngol Otol       Date:  2009-01-12       Impact factor: 1.469

10.  The Hannover experience: surgical treatment of tongue cancer--a clinical retrospective evaluation over a 30 years period.

Authors:  Horst Kokemueller; Majeed Rana; Jennifer Rublack; Andre Eckardt; Frank Tavassol; Paul Schumann; Daniel Lindhorst; Martin Ruecker; Nils-Claudius Gellrich
Journal:  Head Neck Oncol       Date:  2011-05-21
View more
  6 in total

1.  Computed tomography detection of extracapsular spread of squamous cell carcinoma of the head and neck in metastatic cervical lymph nodes.

Authors:  Joshua A Carlton; Adam W Maxwell; Lyndsey B Bauer; Sara M McElroy; Lester J Layfield; Humera Ahsan; Ajay Agarwal
Journal:  Neuroradiol J       Date:  2017-03-08

2.  Can MR textural analysis improve the prediction of extracapsular nodal spread in patients with oral cavity cancer?

Authors:  Russell Frood; Ebrahim Palkhi; Mark Barnfield; Robin Prestwich; Sriram Vaidyanathan; Andrew Scarsbrook
Journal:  Eur Radiol       Date:  2018-06-05       Impact factor: 5.315

3.  Classifying Neck Lymph Nodes of Head and Neck Squamous Cell Carcinoma in MRI Images with Radiomic Features.

Authors:  Tsung-Ying Ho; Chun-Hung Chao; Shy-Chyi Chin; Shu-Hang Ng; Chung-Jan Kang; Ngan-Ming Tsang
Journal:  J Digit Imaging       Date:  2020-06       Impact factor: 4.056

4.  Histopathological Definitions of Extranodal Extension: A Systematic Review.

Authors:  Chadi Nimeh Abdel-Halim; Tine Rosenberg; Stine Rosenkilde Larsen; Poul Flemming Høilund-Carlsen; Jens Ahm Sørensen; Max Rohde; Christian Godballe
Journal:  Head Neck Pathol       Date:  2020-09-12

5.  Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent Chemoradiotherapy.

Authors:  Abhishek Mahajan; Ankur Chand; Ujjwal Agarwal; Vijay Patil; Richa Vaish; Vanita Noronha; Amit Joshi; Akhil Kapoor; Nilesh Sable; Ankita Ahuja; Shreya Shukla; Nandini Menon; Jai Prakash Agarwal; Sarbani Ghosh Laskar; Anil D' Cruz; Pankaj Chaturvedi; Devendra Chaukar; P S Pai; Gouri Pantvaidya; Shivakumar Thiagarajan; Swapnil Rane; Kumar Prabhash
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

Review 6.  HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.

Authors:  Matt Lechner; Jacklyn Liu; Liam Masterson; Tim R Fenton
Journal:  Nat Rev Clin Oncol       Date:  2022-02-01       Impact factor: 65.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.